Around 1 in 5 people diagnosed with cancer in the UK take part in a clinical trial.
A study of matching new treatments to the individual make up of pancreatic cancer (Precision-Panc)
This study is looking at tissue samples in detail to try to match people to treatment for pancreatic cancer. It is part of a larger research programme looking at new treatments for pancreatic cancer.
Cancer Research UK supports this study.
More about this trial
- PRIMUS-001 for people with pancreatic cancer that has spread
- PRMUS-002 for people with pancreatic cancer that can be removed with surgery (please note, PRIMUS-002 is now closed)
- PRIMUS-003 for people having their 2nd treatment for pancreatic cancer that has spread elsewhere in the body (please note, PRIMUS-003 is now closed)
- PRIMUS-005 (STARPAC-2) for people whose cancer has grown just outside the pancreas and it isn’t possible to have surgery to remove it (please note, PRIMUS-005 is currently on hold)
Who can enter
- have the most common type of pancreatic cancer called ductal adenocarcinoma of the pancreas
- have a mass that your doctor suspects is cancer of the pancreas which may or may not have spread elsewhere in the body
- are willing to give tissue samples (biopsies)
- are considered to be suitable to join an open PRIMUS study
- are suitable to have treatment such as surgery, chemotherapy or radiotherapy
- are at least 16 years old
- the genetic make up of your cancer
- any inherited cancer genes passed down to you by your mother or father
You shouldn’t have any extra hospital visits if you join this study.
How to join a clinical trial
Professor Andrew Biankin
Dr David Chang
Cancer Research UK
NHS Greater Glasgow and Clyde